Fyarro - Drug Details
๐Ÿ“Š Estimates Fyarro Dialyzability By Different_Modalities

Fyarro

Complete Drug Information

Drug Name
Fyarro
Trade Names
Rapamune
Pregnancy Category
AU: C
Bioavailability
14% (oral solution), lower with high-fat meals; 18% (tablet), higher with high-fat meals
Routes of Administration
Oral, intravenous, topical
Protein Binding
92%%
Metabolism
Liver
Elimination
57โ€“63 hours
Excretion
Mostly fecal
Formula
C51H79NO13
Molar Mass
914.187
Volume of Distribution
C51H79NO13

๐Ÿคฐ Pregnancy Category Information

Category: AU: C

Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible.